Arkolith/Insider Trading/VRDN/Form 4

Meisner Lara

Chief Legal OfficerViridian Therapeutics, Inc.\DE (VRDN) · full profile →Form 4 · filed Jun 20, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$64K
Net Open-Market Flow
-$64K
Transactions
6
4 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 16, 2023Sell(S)27$28.35$76530K
Jun 16, 2023Option exercise(M)27$23.03$62230K
Jun 15, 2023Sell(S)2K$28.02$64K30K
Jun 15, 2023Option exercise(M)2K$23.03$52K32K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 16, 2023Option exercise(M)28—$037K
Jun 15, 2023Option exercise(M)2K—$037K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-23-015998) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML